Eisai Drops Perampanel In Parkinson’s, Plans First Neuropathy Submission For 2010
This article was originally published in The Pink Sheet Daily
Executive Summary
New studies in neuropathic pain and epilepsy employ doses up to 12mg, compared to 2mg and 4mg doses in Parkinson’s studies.